48,830
edits
(→Tumours of uncertain differentiation: +images, chondrosarcoma) |
|||
(233 intermediate revisions by 2 users not shown) | |||
Line 1: | Line 1: | ||
'''Soft tissue | '''Soft tissue lesions''' strike fear in many pathologists as they are uncommon and may be difficult to diagnose. Malignant soft tissue lesions, i.e. [[cancer|cancerous]] soft tissue lesions, are usually '''sarcomas'''. Sarcomas are malignancies derived from mesenchymal tissue. | ||
==WHO classification of soft tissue tumours== | =Introduction= | ||
===Morphologic grouping<ref>WMSP | ==WHO classification of soft tissue lesions/tumours== | ||
#Adipocytic tumours. | ===Morphologic grouping=== | ||
#Fibroblastic/myofibroblastic tumours. | These include:<ref name=Ref_WMSP601-3>{{Ref WMSP|601-3}}</ref> | ||
#"Fibrohistiocytic" tumours. | #[[Adipocytic tumours]]. | ||
#Smooth muscle tumours. | #[[Fibroblastic/myofibroblastic tumours]]. | ||
#Skeletal muscle tumours. | #[[Fibrohistiocytic tumours|"Fibrohistiocytic" tumours]]. | ||
#Vascular tumours. | #[[Smooth muscle tumours|Smooth muscle tumours]]. | ||
#Perivascular (pericytic) tumours. | #[[Soft tissue lesions#Skeletal muscle tumours|Skeletal muscle tumours]]. | ||
#Chondro-osseous tumours. | #[[Vascular tumours]]. | ||
#Tumours of uncertain differentiation. | #[[Soft_tissue_lesions#Perivascular_tumours|Perivascular (pericytic) tumours]]. | ||
#[[Chondro-osseous tumours]]. | |||
#[[Soft tissue lesions#Tumours of uncertain differentiation|Tumours of uncertain differentiation]]. | |||
===Biologic potential grouping<ref>WMSP | ===Biologic potential grouping=== | ||
These include:<ref>{{Ref WMSP|598-604}}</ref> | |||
#Benign. | #Benign. | ||
#Intermediate (locally aggressive). | #Intermediate (locally aggressive). | ||
Line 19: | Line 22: | ||
#Malignant. | #Malignant. | ||
= | ==Prevalence== | ||
*All sarcomas are rare buggers. | |||
**As the classification has been changing over the past years (with more subtypes being recognized/identified) numbers are variable from study-to-study. | |||
*Once upon a time almost everything was called ''malignant fibrous histiocytoma''; thus, it is listed as a common entity in some publications. | |||
=== | Most common:<ref name=pmid17976362>{{cite journal |author=Skubitz KM, D'Adamo DR |title=Sarcoma |journal=Mayo Clin. Proc. |volume=82 |issue=11 |pages=1409–32 |year=2007 |month=November |pmid=17976362 |doi= |url= http://www.mayoclinicproceedings.com/content/82/11/1409.long}}</ref> | ||
*Liposarcoma. | |||
* | *Leiomyosarcoma. | ||
* | |||
== | ==Molecular testing== | ||
{{Main|Molecular pathology}} | |||
*Molecular testing plays an important role in soft tissue pathology. | |||
*It is generally seen as an adjunct test that:<ref name=pmid11454050>{{cite journal |author=Fletcher CD, Fletcher JA, Dal Cin P, Ladanyi M, Woodruff JM |title=Diagnostic gold standard for soft tissue tumours: morphology or molecular genetics? |journal=Histopathology |volume=39 |issue=1 |pages=100–3 |year=2001 |month=July |pmid=11454050 |doi= |url=}}</ref> | |||
**Often is used to confirm the histomorphologic impression/quality control. | |||
**Frequently has some prognostic significance. | |||
**May directly affect treatment. | |||
== | ===Translocations=== | ||
{{Main|Chromosomal translocations}} | |||
*Many tumours in soft tissue pathology are diagnosed inconjunction with the finding of [[chromosomal translocations]]. | |||
=== | ==Morphohistologic patterns== | ||
{{Main|Morphologic patterns}} | |||
{| class="wikitable sortable" style="margin-left:auto;margin-right:auto" | |||
! Name | |||
! Description | |||
! DDx | |||
! Image(s) | |||
|- | |||
| Storiform, [[AKA]] patternless pattern<ref name=pmid9704618>{{cite journal |author=Mangano WE, Cagle PT, Churg A, Vollmer RT, Roggli VL |title=The diagnosis of desmoplastic malignant mesothelioma and its distinction from fibrous pleurisy: a histologic and immunohistochemical analysis of 31 cases including p53 immunostaining |journal=Am. J. Clin. Pathol. |volume=110 |issue=2 |pages=191–9 |year=1998 |month=August |pmid=9704618 |doi= |url=}}</ref> | |||
| whorled, cartwheel-like arrangement | |||
| [[pleomorphic undifferentiated sarcoma]], [[solitary fibrous tumour]], [[dermatofibrosarcoma protuberans]], [[dermatofibroma]]<ref name=pmid224569>{{cite journal |author=Meister P, Höhne N, Konrad E, Eder M |title=Fibrous histiocytoma: an analysis of the storiform pattern |journal=Virchows Arch A Pathol Anat Histol |volume=383 |issue=1 |pages=31–41 |year=1979 |month=July |pmid=224569 |doi= |url=}}</ref> | |||
| [[Image:Storiform_pattern_-_intermed_mag.jpg |thumb|center|150px| Patternless pattern. (WC)]] | |||
|- | |||
| Herring bone | |||
| like herring bone (technique) for climbing a hill in cross country skiing; books on a shelf, where they have partially fallen over -- on the one shelf to the left and the one below to the right | |||
| [[fibrosarcoma]], [[synovial sarcoma]], [[MPNST]] | |||
| [[Image:Malignant_peripheral_nerve_sheath_tumour_-_intermed_mag.jpg |thumb|center|150px |Herring bone. (WC)]] | |||
|- | |||
| Fascicular | |||
| the long axis of the (spindle) cells are perpendicular to one another in adjacent bundles of cells | |||
| [[leiomyoma]], [[leiomyosarcoma]] | |||
| [[Image:Cutaneous_leiomyosarcoma_-_high_mag.jpg |thumb|center|150px| Fascicular pattern. (WC)]] | |||
|- | |||
| Biphasic | |||
| nests of cells and stroma | |||
| [[synovial sarcoma]], [[DSRCT]], [[alveolar RMS]] | |||
| [[Image:Desmoplastic_small_round_cell_tumour_-_high_mag.jpg|thumb|center|150px| DSRCT. (WC)]] | |||
|- <!-- | |||
| name ? | |||
| description ? | |||
| DDx ? | |||
| image ? --> | |||
|} | |||
Notes: | |||
*Memory device: herring bone DDx ''MSF'' = MPNST, Synovial sarcoma, Fibrosarcoma. | |||
* | |||
= | ==Grading== | ||
*Several systems exist. | |||
*The US-CAP advocates the use of the French system over the NCI system. | |||
* | **The French system is a better predictor metastases and mortality.<ref name=pmid8996162>{{cite journal |author=Guillou L, Coindre JM, Bonichon F, ''et al.'' |title=Comparative study of the National Cancer Institute and French Federation of Cancer Centers Sarcoma Group grading systems in a population of 410 adult patients with soft tissue sarcoma |journal=J. Clin. Oncol. |volume=15 |issue=1 |pages=350–62 |year=1997 |month=January |pmid=8996162 |doi= |url=}}</ref> | ||
* | |||
* | |||
=== | ===French system=== | ||
* | *Formally known as the grading system from the ''French Federation of Cancer Centres Sarcoma Group'' (FNCLCC). | ||
=== | ====Overview==== | ||
Components - overview:<ref name=pmid8996162/><ref name=uscap_stp>URL: [http://www.cap.org/apps/docs/committees/cancer/cancer_protocols/2011/SoftTissue_11protocol.pdf http://www.cap.org/apps/docs/committees/cancer/cancer_protocols/2011/SoftTissue_11protocol.pdf]. Accessed on: 12 April 2011.</ref> | |||
* | #Differentiation (score 1-3). | ||
#*De facto, this is mostly the ''histologic type''. | |||
#Mitotic rate (score 1-3). | |||
#Necrosis (score 0-2) | |||
Obtaining a score: | |||
*Add all the points from the three components. | |||
* | |||
Scoring: | |||
* | *Grade 1 = 2-3. | ||
*Grade 2 = 4-5. | |||
*Grade 3 = 6-8. | |||
== | =====Differentiation===== | ||
*Most | *Standardized for histologic types. | ||
*Most tumours = 3/3. | |||
= | Exceptions:<ref name=uscap_stp/> | ||
*Well-differentiated liposarcoma = 1. | |||
* | *Myxoid liposarcoma = 2. | ||
* | *Conventional [[liposarcoma]] = 2. | ||
* | *Fibrosarcoma = 2. | ||
*[[Myxofibrosarcoma]] =2. | |||
* | |||
* | |||
A group of tumours is not graded:<ref name=uscap_stp/> | |||
*[ | *[[MPNST]]. | ||
*[ | *[[Rhabdomyosarcoma]]. | ||
*[ | *[[Alveolar soft part sarcoma]]. | ||
*[[Clear cell sarcoma]]. | |||
*[[Extraskeletal myxoid chondrosarcoma]]. | |||
=== | =====Mitotic rate===== | ||
* | *0-9 mitoses/10 HPF. | ||
*10-19 mitoses/10 HPF. | |||
*>=20 mitoses/10 HPF. | |||
* | Notes: | ||
* | *1 HPF = 0.1734 mm^2. | ||
**Most resident microscopes have a field of view = 0.2376 mm^2. | |||
***Thus, ~7.3 HPFs on a resident microscope corresponds to 10 US-CAP HPFs. | |||
= | =====Necrosis===== | ||
== | *None = score 0. | ||
*<=50% of tumour = score 1. | |||
*>50% of tumour = score 2. | |||
=== | ===System used by some at MSH=== | ||
Some pathologists at [[MSH]] use the system advocated by Costa et al..<ref name=pmid6692258>{{cite journal |author=Costa J, Wesley RA, Glatstein E, Rosenberg SA |title=The grading of soft tissue sarcomas. Results of a clinicohistopathologic correlation in a series of 163 cases |journal=Cancer |volume=53 |issue=3 |pages=530–41 |year=1984 |month=February |pmid=6692258 |doi= |url=}}</ref> | |||
= | ====Scoring==== | ||
*Grade 1 = 1 point. | |||
*Grade 2 = 2 points. | |||
*Grade 3 = 3-4 points. | |||
== | ====Components==== | ||
* | Points for each of the following: | ||
*Mitotic activity >= 6 / 10 HPF @ 40X - definition suffers from [[HPFitis]]. | |||
*Pleomorphism present. | |||
*Cellularity (cells/matrix) > 50%. | |||
*Necrosis >15% - microscopic (without targeting necrosis grossly) ''or'' grossly. | |||
== | ==Stage== | ||
=== | {{Main|Cancer staging systems}} | ||
* | ===Lymph node metastases in sarcomas=== | ||
* | {{Main|Lymph node metastasis}} | ||
* | *[[Lymph node]] (LN) spread is uncommon in sarcomas; [[lymph node metastases]] are seen in <3% of cases.<ref name=pmid8424704>{{Cite journal | last1 = Fong | first1 = Y. | last2 = Coit | first2 = DG. | last3 = Woodruff | first3 = JM. | last4 = Brennan | first4 = MF. | title = Lymph node metastasis from soft tissue sarcoma in adults. Analysis of data from a prospective database of 1772 sarcoma patients. | journal = Ann Surg | volume = 217 | issue = 1 | pages = 72-7 | month = Jan | year = 1993 | doi = | PMID = 8424704 | PMC = 1242736}}</ref> | ||
**Many sarcomas are reported in LNs. | |||
***According to the [[CAP checklist]] for soft tissue<ref>URL: [http://www.cap.org/apps/docs/committees/cancer/cancer_protocols/2011/SoftTissue_11protocol.pdf http://www.cap.org/apps/docs/committees/cancer/cancer_protocols/2011/SoftTissue_11protocol.pdf]. Accessed on: 28 March 2012.</ref> the most common are: [[epithelioid sarcoma]] and [[clear cell sarcoma]]. | |||
***According to Fong ''et al.''<ref name=pmid8424704/> the most commonly is: angiosarcoma. | |||
Sarcomas more likely to be found in the lymph nodes - mnemonic ''RACE For MS'':<ref>URL: [http://www.aippg.net/forum/f21/surgery-mnemonics-79897/ http://www.aippg.net/forum/f21/surgery-mnemonics-79897/]. Accessed on: 23 March 2012.</ref> | |||
* | *[[rhabdomyosarcoma|'''R'''habdomyosarcoma]] | ||
*[[Angiosarcoma|'''A'''ngiosarcoma]]. | |||
*[[clear cell sarcoma|'''C'''lear cell sarcoma]]. | |||
*[[epithelioid sarcoma|'''E'''pitheliod sarcoma]]. | |||
*[[fibrosarcoma|'''F'''ibrosarcoma]]. | |||
*[[pleomorphic undifferentiated sarcoma|'''M'''alignant fibrous histiocytoma (pleomorphic undifferentiated sarcoma)]]. | |||
*[[synovial sarcoma|'''S'''ynovial cell sarcoma]]. | |||
==== | ==DDx by history/site== | ||
===Retroperiteum=== | |||
#[[Liposarcoma]]. | |||
#[[Undifferentiated pleomorphic sarcoma]]. | |||
#[[Leiomyosarcoma]]. | |||
#[[MPNST]]. | |||
Note: | |||
[[Synovial sarcoma]] and [[fibrosarcoma]] are very rare in the retroperitoneum. | |||
=== | ===Young person - extremity sarcoma=== | ||
#[[Epithelioid sarcoma]]. | |||
#[[Synovial sarcoma]]. | |||
=== | ==Gross characteristics== | ||
*Usually non-specific. | |||
*Most sarcomas have a pushing border. | |||
* | **If there is an infiltrative border think: (1) fibromatosis, (2) carcinoma. | ||
* | |||
* | |||
* | |||
= | =Adipocytic tumours= | ||
{{Main|Adipocytic tumours}} | |||
This category includes: | |||
* | *Lipoma. | ||
* | *Liposarcoma. | ||
* | *Hibernoma. | ||
== | =Smooth muscle tumours= | ||
{{Main|Smooth muscle tumours}} | |||
IHC markers: desmin, SMA, H-caldemsin (most specific). | |||
= | ==Leiomyosarcoma== | ||
{{Main|Leiomyosarcoma}} | |||
=== | ===Microscopic=== | ||
Features (summary): | |||
*Fasicular cellular spindle cell lesion with: | |||
**Nuclear atypia. | |||
**[[Necrosis]]. | |||
**High mitotic rate. | |||
=== | =Fibrohistiocytic tumours= | ||
''Fibrohistiocytic'' refers (only) to the histomorphologic appearance and therefore may be written in quotation marks; these tumours are not derived from histiocytes (or tissue macrophages), as the name implies.<ref name=pmid20055912>{{Cite journal | last1 = Luzar | first1 = B. | last2 = Calonje | first2 = E. | title = Cutaneous fibrohistiocytic tumours - an update. | journal = Histopathology | volume = 56 | issue = 1 | pages = 148-65 | month = Jan | year = 2010 | doi = 10.1111/j.1365-2559.2009.03447.x | PMID = 20055912 }}</ref> | |||
==Pleomorphic undifferentiated sarcoma== | |||
* | *Abbreviated ''PUS''. | ||
*[[AKA]] ''Undifferentiated pleomorphic sarcoma'', abbreviated ''UPS''. | |||
*Previously known as ''malignant fibrous histiocytoma'', abbreviated ''MFH''.<ref>URL: [http://sarcomahelp.org/learning_center/mfh.html http://sarcomahelp.org/learning_center/mfh.html]. Accessed on: 8 April 2011.</ref> | |||
{{Main|Pleomorphic undifferentiated sarcoma}} | |||
= | =Fibroblastic/myofibroblastic tumours= | ||
{{Main|Fibroblastic/myofibroblastic tumours}} | |||
This is a very large and important group of soft tissue lesions. It is covered in a separate article. | |||
The grouping includes: | |||
*[[Inflammatory myofibroblastic tumour]]. | |||
* | *[[Nodular fasciitis]]. | ||
** | *[[Desmoid-type fibromatosis]] (Desmoid tumour). | ||
* | *[[Proliferative fasciitis]]. | ||
* | *[[Solitary fibrous tumour]] ([[Hemangiopericytoma]]). | ||
** | *[[Desmoplastic fibroblastoma]]. | ||
*[[Low-grade fibromyxoid sarcoma]]. | |||
*Others. | |||
== | =Perivascular tumours= | ||
* | This grouping includes only two:<ref name=Ref_WMSP602>{{Ref WMSP|602}}</ref> | ||
*[[Glomus tumour]] - both benign and malignant. | |||
*[[Myopericytoma]]. | |||
== | =Vascular lesions= | ||
{{Main|Vascular lesions}} | |||
Vascular lesions are "too red"; they have too many RBCs. | |||
They include: | |||
* | *[[Hemangioma]]. | ||
*[[Kaposi sarcoma]]. | |||
*[[Masson hemangioma]]. | |||
*[[Angiosarcoma]] | |||
*[[Epithelioid hemangioendothelioma]]. | |||
=Skeletal muscle tumours= | =Skeletal muscle tumours= | ||
==Rhabdomyoma== | |||
{{Main|Rhabdomyoma}} | |||
==Rhabdomyosarcoma== | ==Rhabdomyosarcoma== | ||
* | *Abbreviated ''RMS''. | ||
{{Main|Rhabdomyosarcoma}} | |||
Comes it two main flavours: | |||
*Alveolar rhabdomyosarcoma. | |||
*Embryonal rhabdomyosarcoma. | |||
The histology may be that of a [[small round cell tumour]]. | |||
== | =Chondro-osseous tumours= | ||
{{Main|Chondro-osseous tumours}} | |||
This grouping includes tumours derived from [[cartilage]] and [[bone]]. | |||
=Tumours of uncertain differentiation= | =Tumours of uncertain differentiation= | ||
== | ==Angiomatoid fibrous histiocytoma== | ||
{{Main|Angiomatoid fibrous histiocytoma}} | |||
== | ==Aggressive angiomyxoma== | ||
* | *[[AKA]] deep aggressive angiomyxoma. | ||
{{Main|Aggressive angiomyxoma}} | |||
=== | ==Angiomyofibroblastoma== | ||
{{Main|Angiomyofibroblastoma}} | |||
==Extrarenal malignant rhabdoid tumour== | |||
*[ | *Essentially identical to ''[[renal malignant rhabdoid tumour]]''.<ref name=Ref_WMSP627>{{Ref WMSP|627}}</ref> | ||
{{Main|Extrarenal malignant rhabdoid tumour}} | |||
=== | ==Ewing sarcoma/PNET== | ||
{{Main|Ewing sarcoma}} | |||
*A [[small round blue cell tumour]] that may be seen in [[bone]]. It is discussed in the context of [[bone tumours]]. | |||
* | |||
==Epithelioid sarcoma== | |||
:Sarcomas with an epithelioid morphology are covered in ''[[epithelioid sarcomas]]''. | |||
{{Main|Epithelioid sarcoma}} | |||
=== | ==Alveolar soft part sarcoma== | ||
{{Main|Alveolar soft part sarcoma}} | |||
== | ==Desmoplastic small round cell tumour== | ||
{{Main|Desmoplastic small round cell tumour}} | |||
==Clear cell sarcoma== | |||
{{Main|Clear cell sarcoma}} | |||
==Synovial sarcoma== | |||
{{Main|Synovial sarcoma}} | |||
=== | =Other= | ||
==Granulocytic sarcoma== | |||
*Common alternate terms: extramedullary leukemia,<ref name=pmid21795742>{{Cite journal | last1 = Bakst | first1 = RL. | last2 = Tallman | first2 = MS. | last3 = Douer | first3 = D. | last4 = Yahalom | first4 = J. | title = How I treat extramedullary acute myeloid leukemia. | journal = Blood | volume = 118 | issue = 14 | pages = 3785-93 | month = Oct | year = 2011 | doi = 10.1182/blood-2011-04-347229 | PMID = 21795742 }}</ref> myeloid sarcoma, chloroma. | |||
* | *Other terms:<ref name=pmid21556238>{{Cite journal | last1 = Eom | first1 = KS. | last2 = Kim | first2 = TY. | title = Intraparenchymal myeloid sarcoma and subsequent spinal myeloid sarcoma for acute myeloblastic leukemia. | journal = J Korean Neurosurg Soc | volume = 49 | issue = 3 | pages = 171-4 | month = Mar | year = 2011 | doi = 10.3340/jkns.2011.49.3.171 | PMID = 21556238 | PMC = 3085814 | url = http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3085814/ }}</ref> myeloblastoma, chloromyeloma, chloromyelosarcoma, granulocytic leukosarcoma, or myelosarcoma. | ||
{{Main|Granulocytic sarcoma}} | |||
=See also= | =See also= | ||
Line 348: | Line 315: | ||
*[[Hematopathology]]. | *[[Hematopathology]]. | ||
*[[Spindle cell lesion]]. | *[[Spindle cell lesion]]. | ||
*[[Neurofibromatosis]]. | |||
*[[Small round cell tumours]]. | |||
=References= | =References= | ||
{{reflist|2}} | {{reflist|2}} | ||
[[Category: | [[Category:Soft tissue lesions]] |
edits